Jyothy Labs Ltd
NSE: JYOTHYLAB BSE: 532926
₹188.13
-0.11 (0.06%)
Sat, 07 Nov 2026, 00:07 am
Market Cap (in Cr)6918.72
PE Ratio24.32
Dividend1.86
Jyothy Labs Analysis
dividend
Pros
- Dividends per share have increased over the past 10 years.
- Dividends paid are covered by earnings (1.5x coverage).
- Dividends after 3 years are expected to be well covered by earnings (2.2x coverage).
- Jyothy Labs's pays a higher dividend yield than the bottom 25% of dividend payers in India (0.76%).
Cons
- Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
- Jyothy Labs's dividend is below the markets top 25% of dividend payers in India (3.08%).
future
Pros
- Jyothy Labs's earnings growth is expected to exceed the low risk savings rate of 7.2%.
- Jyothy Labs's earnings are expected to exceed the low risk growth rate next year.
- Jyothy Labs's earnings are expected to increase by more than the low risk growth rate in 3 years time.
- Performance (ROE) is expected to be above the current Asia Household Products industry average.
- An improvement in Jyothy Labs's performance (ROE) is expected over the next 3 years.
- Jyothy Labs's revenue growth is expected to exceed the India market average.
Cons
- Cash flow for Jyothy Labs is expected to increase but not above the 50% threshold in 2 years time.
- Jyothy Labs's earnings are expected to grow by 11.4% yearly, however this is not considered high growth (20% yearly).
- Jyothy Labs's earnings growth is positive but not above the India market average.
- Jyothy Labs's net income is expected to increase but not above the 50% threshold in 2 years time.
- Jyothy Labs is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
- Jyothy Labs's revenue is expected to increase but not above the 50% threshold in 2 years time.
- Jyothy Labs's revenue is expected to grow by 7.3% yearly, however this is not considered high growth (20% yearly).
health
Pros
- Jyothy Labs is profitable, therefore cash runway is not a concern.
- Jyothy Labs is profitable, therefore cash runway is not a concern.
- Debt is well covered by operating cash flow (77.5%, greater than 20% of total debt).
- Debt is covered by short term assets, assets are 2x debt.
- Jyothy Labs's cash and other short term assets cover its long term commitments.
- The level of debt compared to net worth has been reduced over the past 5 years (72.9% vs 18.4% today).
- Interest payments on debt are well covered by earnings (EBIT is 6.6x coverage).
- Jyothy Labs's level of debt (18.4%) compared to net worth is satisfactory (less than 40%).
Cons
- Jyothy Labs's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
- High level of physical assets or inventory.
management
Pros
- The average tenure for the Jyothy Labs board of directors is over 10 years, this suggests they are a seasoned and experienced board.
- Kasaragod's compensation has been consistent with company performance over the past year, both up more than 20%.
- The average tenure for the Jyothy Labs management team is over 5 years, this suggests they are a seasoned and experienced team.
Cons
- Kasaragod's remuneration is higher than average for companies of similar size in India.
past
Pros
- Jyothy Labs's year on year earnings growth rate has been positive over the past 5 years.
- Jyothy Labs used its assets more efficiently than the Asia Household Products industry average last year based on Return on Assets.
Cons
- Jyothy Labs's 1-year earnings growth is negative, it can't be compared to the 5-year average.
- Jyothy Labs's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
- Jyothy Labs has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
- Jyothy Labs's 1-year earnings growth is negative, it can't be compared to the Asia Household Products industry average.
value
Pros
- NSEI:JYOTHYLAB is up 12% outperforming the Household Products industry which returned 2.6% over the past month.
- NSEI:JYOTHYLAB is up 12% outperforming the market in India which returned 8% over the past month.
Cons
- Jyothy Labs's share price is above the future cash flow value, it's not available at a moderate discount (< 20%).
- Jyothy Labs's share price is above the future cash flow value, it's not available at a substantial discount (< 40%).
- Jyothy Labs is overvalued based on assets compared to the IN Household Products industry average.
- Jyothy Labs is poor value based on expected growth next year.
- Jyothy Labs is overvalued based on earnings compared to the Asia Household Products industry average.
- Jyothy Labs is overvalued based on earnings compared to the India market.
- JYOTHYLAB underperformed the Household Products industry which returned 13.9% over the past year.
- JYOTHYLAB underperformed the Market in India which returned -14.5% over the past year.